Promising Clinical Outcomes and Financial Stability Support Buy Rating for Black Diamond Therapeutics
TD Cowen analyst Marc Frahm has maintained their bullish stance on BDTX stock, giving a Buy rating today. Marc Frahm’s rating is based ...